The International Obesity TaskForce has published paediatric cutoffs from the age of 2 years for overweight and obesity, based on adult thresholds. We question their rationale. The adult cutoffs were based on known health risk; the children's were not. Data from the EarlyBird Study show that BMI category for overweight and obesity in young children are poor markers of insulin resistance and, by implication, of metabolic risk and diabetes. Moreover, BMI is known to track poorly from early childhood to adulthood. We know even less about the tracking of insulin resistance and other indices of metabolic risk from the earliest years. Until we understand more about which children acquire such risk factors, any such thresholds for overweight and obesity should be used with caution in the very young, as they may unnecessarily stigmatise the heavier child.
, respectively. They were not intended for clinical use but to assess trends and to compare populations. Notwithstanding this, IOTF cutoffs for paediatric 'overweight' and 'obesity' were added to the UK charts and used in the clinic.
Labelling children in this categorical way, at a very early age, raises a number of concerns. First, the cutoffs are based on the unfounded assumption that a fixed proportion of children, even at the age of 2 years, is overweight or obese. Second, they are derived from cross-sectional data, and therefore not predictive. Although centile charts drawn from cross-sectional data give the impression of clinical continuity, they do not describe the tracking of individual children. In reality, BMI tracks relatively poorly from early childhood to adulthood. Hesketh found that 20% of 'obese' 5-10 year olds had spontaneously resolved to a healthy weight within 3 years. 2 Tracking obviously improves the nearer the child gets to adult status, 3, 4 but most adults, at least to date, have not been obese as young children.
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Third, and most importantly, the WHO adult cutoffs were chosen on the basis of established health risk. 9 The children's
were not, and they are arbitrary. In the context of effective child health surveillance, the clinician needs to know whether cutoffs on a centile chart reliably identify children at risk of current or future metabolic disturbance. Weight excess is undoubtedly associated with insulin resistance and metabolic disturbance in adults, 10 but the relationship is not a strong one and the corresponding associations in children are less clear still. As Cole has pointed out, a centile cutoff where the health risk of obesity starts to rise cannot be identified with any precision in children. 1 Clinical validity (association of BMI with current or future morbidity/ mortality) is more important to establish than measurement validity (correlation with body fat). The Bogalusa Study is widely cited as evidence for a relationship between childhood overweight and cardiovascular risk. However, the associations between children's BMI and metabolic disturbance are weak. Probability, which improves with increasing numbers, is wrongly used throughout to argue for strength of association. Correlation, when low, will remain so, however large the numbers or small the P-value.
Of the 2000 5-10-year-olds in the Bogalusa study, most had no risk factors at all. 11 Only eight had more than four components of the metabolic syndrome, and all of them fell into the category of 'overweight' (BMI495th centile). However, 40% of those overweight had no risk factors at all, whereas 22% of those deemed 'normal' had at least one.
As a screening tool, BMI discriminated poorly between those with and without risk. It may provide valuable data for the epidemiologist, but little for the paediatrician. What then of the relationship between BMI status in childhood and metabolic disturbance in adulthood, the outcome measure of principle concern? Often benchmarked as a longitudinal cohort study, Bogalusa is actually a series of seven cross-sectional studies in which only 55% of the participants appear more than once. This is important because cross-sectional data cannot provide information on tracking, only associations within a population at a given time.
The EarlyBird Study was set up in 2000 as a longitudinal study of growth and maturation, with metabolic health as the outcome measure. It involves 300 children and their parents and has obtained fasting blood samples annually from the age of 5 years, in order to monitor the emergence of insulin resistance (HOMA-IR 12 ) and its metabolic impact. 13 Whereas the parents' data show a clear relationship between BMI and HOMA-IR, explaining 28% (41%) of the variance in insulin resistance in the fathers (mothers) (Figure 1 ), the corresponding association in their children aged 5 years is weak, at best explaining 6%. It therefore seems unlikely, given the limited relationship between prepubertal and adult BMI, that a BMI at 5 years will usefully identify those currently at metabolic risk or likely to become so in the future.
When EarlyBird children are classified according to their respective BMI cutoffs as 'normal', 'overweight' and 'obese', there is a uniform stepwise increase in mean insulin resistance according to weight category (Figure 2) . However, categorisation of this kind says nothing about the predictive sensitivity or specificity of BMI. Mean insulin resistance clearly differs between children classified according to IOTF criteria, but the performance of BMI category as a screening tool for individual risk is poor. Triglycerides, a marker for metabolic disturbance, 14 fare no better (data not shown).
BMI is a relatively blunt tool in the early detection of metabolic risk. Change in BMI, over time, would seem to be a more useful marker than a single measure at, for example, school entry. 15 Thus the long-term importance of obesity in childhood remains unclear. 16, 17 We can find no evidence to support the IOTF thresholds for overweight and obesity LD Voss et al categorisation of very young children by BMI into those at risk of metabolic disturbance. It is important to look beyond P-values, which are sample size dependent, to consider effect size. BMI, at this age, does not explain a clinically useful proportion of the variance in either insulin resistance or triglycerides.
BMI is, however, only a proxy for adiposity, the principal factor driving insulin resistance. 18 As others have pointed out, while BMI continues to serve well for many purposes, the time may now be right to move towards standards of adiposity based on direct measures of body fat. 19 We may go further still. As yet, we know little about the tracking of any metabolic risk factor but, as a direct measure of metabolic disturbance, insulin resistance, or its metabolic correlates, may ultimately prove the most useful measure of all in the identification of the child at risk. Understanding the pathogenesis of disease from its earliest development is crucial to its prevention. As a prospective study, EarlyBird will continue to add to that understanding.
In conclusion, the use of any BMI thresholds for overweight and obesity should be used with care in very young children. As a marker for abnormal metabolic indices, BMI does not meet screening criteria. While offering false reassurance to some, others may be unnecessarily stigmatised. 8 Classifying persons as 'normal' or otherwise, according to their BMI, elevates the measure from a screening tool to a diagnostic criterion. 20 Until we are able to specify categories of risk associated with childhood adiposity, populationbased approaches to the prevention of obesity are likely to be more effective than approaches targeted at fat children. 7 The use of IOTF charts should be restricted to the purpose for which they were devised -to assess population trends and to make international comparisons. IOTF thresholds for overweight and obesity LD Voss et al
